← Back to feedRead original →
VERIFIEDET Finance·neutral
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observations
AI Summary
- ·Aurobindo Pharma's subsidiary Lannett Company LLC's facility was inspected by the USFDA.
- ·The inspection took place from August 17-21, 2026, at the Seymour, USA facility.
- ·Four procedural observations were noted during the inspection.